• Announcements Projects News & Events
  • Welcome guest
  • Log in
  • Loading
    Loading...
Announcements
Projects
Orgs
Project
Articles 130
Votes 0
Endpoints News
  • Home
  • Members
  • Articles

Interested in joining Endpoints News?

Create your account and become part of this amazing organization. Start collaborating, sharing ideas, and building connections today!

Join Endpoints News Sign In First
Articles
130
FDA approves Vertex and CRISPR's Casgevy as first CRISPR-edited therapy for beta-thalassemia - Endpoints News
almost2y
Doudna's new venture; Aclaris CEO to step down; Tome's $114M liver disorder deal with Genevant - Endpoints News
almost2y
The Bell Labs of biotech: Stuart Schreiber has billionaire support for new biomedical institute - Endpoints News
almost2y
Novartis doubles down on neurologic gene therapy work with Voyager - Endpoints News
almost2y
Grail has big plans for its blood cancer tests. The first step: Finding a new owner - Endpoints News
almost2y
Lilly, Novo's bet on heart disease starts to take shape, and 2024 could be a pivotal year for their GLP-1s - Endpoints News
almost2y
Modal title
...
Rate stuff here
Profile
Loading profile
Loading...